A phase 1 study of denintuzumab mafodotin (SGN-CD19A) in adults with relapsed or refractory B-lineage acute leukemia (B-ALL) and highly aggressive lymphoma Meeting Abstract
| Authors: | Fathi, A. T.; Borate, U.; DeAngelo, D. J.; O'Brien, M. M.; Trippett, T.; Shah, B. D.; Hale, G. A.; Foran, J. M.; Silverman, L. B.; Tibes, R.; Cramer, S.; Pauly, M.; Kim, S.; Kostic, A.; Huang, X. H.; Pan, Y.; Chen, R. |
| Abstract Title: | A phase 1 study of denintuzumab mafodotin (SGN-CD19A) in adults with relapsed or refractory B-lineage acute leukemia (B-ALL) and highly aggressive lymphoma |
| Meeting Title: | 57th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 126 |
| Issue: | 23 |
| Meeting Dates: | 2015 Dec 5-8 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2015-12-03 |
| Language: | English |
| ACCESSION: | WOS:000368019004128 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V126.23.1328.1328 |
| Notes: | Meeting Abstract: 1328 -- 57th Annual Meeting of the American-Society-of-Hematology -- DEC 05-08, 2015 -- Orlando, FL -- Source: Wos |
